"Aerpio Pharmaceuticals, Quantum to Evaluate Razuprotafib in New Study Under COVID-19 Program"
ARPO getting a lot of PM attention. This has the potential to have a large run. Looks like a gap from 1.50s to the 3.50-4 area. This will be my top watch today.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.